Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |